Global NGS Sample Preparation Market by Product (Reagent & Consumables, and NGS Workstations), By Workflow (Library Preparation [DNA, RNA], Target Enrichment (Targeted Sequencing, Whole Exome Sequencing and Others) and Quality Control), By Technology (Sequencing By Synthesis (Sbs), Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing (Smrt), Nanopore Sequencing and Others), By Application (Diagonsis(Infectious Disease, Cancer Diagnostics and Reproductive Health Diagnostics), Drug Discovery, Agricultural & Animal Research, and Others),By End-User(Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Global NGS Sample Preparation Market
Report Content
1.	Research Strategic Development
1.1.	Market Modelling
1.2.	Product Analysis
1.3.	Market Trend and Economic Factors Analysis
1.4.	Market Segmental Analysis
1.5.	Geographical Mapping
1.6.	Country Wise Segregation
2.	Research Methodology
2.1.	Identification of Target Market
2.2.	Data Acquisition 
2.3.	Refining of Data/ Data Transformations
2.4.	Data Validation through Primary Techniques
2.5.	Exploratory Data Analysis
2.6.	Graphical Techniques/Analysis
2.7.	Quantitative Techniques/Analysis
2.8.	Visual Result/Presentation 
3.	Executive Summary
4.	Market Insights
4.1.	Economic Factor Analysis 
4.1.1.	Drivers
4.1.2.	Trends
4.1.3.	Opportunities
4.1.4.	Challenges
4.2.	Technological Landscape
4.3.	Competitors & Product Analysis
4.4.	Regulatory Framework
4.5.	Company market share analysis, 2019
4.6.	Porter's Five forces analysis
4.7.	New Investment Analysis
4.8.	PESTEL Analysis
5.	Global NGS Sample Preparation Market Overview
5.1.	Market Size & Forecast, 2016-2027
5.1.1.	Demand
5.1.1.1.	By Value (USD Million)
5.2.	Market Share & Forecast, 2016-2027
5.2.1.	By Product 
5.2.1.1.	Reagent & Consumables
5.2.1.2.	Workstations
5.2.2.	By Workflow 
5.2.2.1.	Library Preparation 
5.2.2.1.1.	DNA
5.2.2.1.2.	RNA
5.2.2.2.	Target Enrichment 
5.2.2.2.1.	Targeted Sequencing
5.2.2.2.2.	Whole Exome Sequencing
5.2.2.2.3.	Others
5.2.2.3.	Quality Control
5.2.3.	By Technology 
5.2.3.1.	Sequencing By Synthesis (Sbs)
5.2.3.2.	Ion Semiconductor Sequencing
5.2.3.3.	Single-Molecule Real-Time Sequencing (Smrt)
5.2.3.4.	Nanopore Sequencing
5.2.3.5.	Others
5.2.4.	By Application 
5.2.4.1.	Diagnosis
5.2.4.1.1.	Infectious Disease
5.2.4.1.2.	Cancer Diagnostics
5.2.4.1.3.	Reproductive Health Diagnostics
5.2.4.2.	 Drug Discovery,
5.2.4.3.	Agricultural & Animal Research
5.2.4.4.	Others
5.2.5.	By End-User
5.2.5.1.	Academic Institutes & Research Centers
5.2.5.2.	Hospitals & Clinics
5.2.5.3.	Pharmaceutical & Biotechnology Companies 
5.2.5.4.	Others
5.2.6.	By Region
5.2.6.1.	North America
5.2.6.2.	Europe
5.2.6.3.	Asia Pacific
5.2.6.4.	South America 
5.2.6.5.	Middle East & Africa 
6.	North America NGS Sample Preparation Market Overview
6.1.	North America NGS Sample Preparation Market Size & Forecast, 2016-2027
6.1.1.	Demand
6.1.1.1.	By Value (USD Million)
6.2.	North America NGS Sample Preparation Market Share & Forecast, 2016-2027
6.2.1.	By Product 
6.2.1.1.	Reagent & Consumables
6.2.1.2.	Workstations
6.2.2.	By Workflow 
6.2.2.1.	Library Preparation 
6.2.2.1.1.	DNA
6.2.2.1.2.	RNA
6.2.2.2.	Target Enrichment 
6.2.2.2.1.	Targeted Sequencing
6.2.2.2.2.	Whole Exome Sequencing
6.2.2.2.3.	Others
6.2.2.3.	Quality Control
6.2.3.	By Technology 
6.2.3.1.	Sequencing By Synthesis (Sbs)
6.2.3.2.	Ion Semiconductor Sequencing
6.2.3.3.	Single-Molecule Real-Time Sequencing (Smrt)
6.2.3.4.	Nanopore Sequencing
6.2.3.5.	Others
6.2.4.	By Application 
6.2.4.1.	Diagnosis
6.2.4.1.1.	Infectious Disease
6.2.4.1.2.	Cancer Diagnostics
6.2.4.1.3.	Reproductive Health Diagnostics
6.2.4.2.	 Drug Discovery,
6.2.4.3.	Agricultural & Animal Research
6.2.4.4.	Others
6.2.5.	By End-User
6.2.5.1.	Academic Institutes & Research Centers
6.2.5.2.	Hospitals & Clinics
6.2.5.3.	Pharmaceutical & Biotechnology Companies 
6.2.5.4.	Others
6.2.6.	By Country
6.2.6.1.	US
6.2.6.2.	Canada
6.2.6.3.	Mexico
6.2.7.	Company Market Share (Top 3-5)
6.2.8.	Economic Impact Study on North America NGS Sample Preparation Market 
7.	Europe NGS Sample Preparation Market Overview
7.1.	Europe NGS Sample Preparation Market Size & Forecast, 2016-2027
7.1.1.	Demand
7.1.1.1.	By Value (USD Million)
7.2.	Europe NGS Sample Preparation Market Share & Forecast, 2016-2027
7.2.1.	By Product 
7.2.1.1.	Reagent & Consumables
7.2.1.2.	Workstations
7.2.2.	By Workflow 
7.2.2.1.	Library Preparation 
7.2.2.1.1.	DNA
7.2.2.1.2.	RNA
7.2.2.2.	Target Enrichment 
7.2.2.2.1.	Targeted Sequencing
7.2.2.2.2.	Whole Exome Sequencing
7.2.2.2.3.	Others
7.2.2.3.	Quality Control
7.2.3.	By Technology 
7.2.3.1.	Sequencing By Synthesis (Sbs)
7.2.3.2.	Ion Semiconductor Sequencing
7.2.3.3.	Single-Molecule Real-Time Sequencing (Smrt)
7.2.3.4.	Nanopore Sequencing
7.2.3.5.	Others
7.2.4.	By Application 
7.2.4.1.	Diagnosis
7.2.4.1.1.	Infectious Disease
7.2.4.1.2.	Cancer Diagnostics
7.2.4.1.3.	Reproductive Health Diagnostics
7.2.4.2.	 Drug Discovery,
7.2.4.3.	Agricultural & Animal Research
7.2.4.4.	Others
7.2.5.	By End-User
7.2.5.1.	Academic Institutes & Research Centers
7.2.5.2.	Hospitals & Clinics
7.2.5.3.	Pharmaceutical & Biotechnology Companies 
7.2.5.4.	Others
7.2.6.	By Country
7.2.6.1.	Germany
7.2.6.2.	UK
7.2.6.3.	France
7.2.6.4.	Italy
7.2.6.5.	Rest of Europe
7.2.7.	Company Market Share (Top 3-5)
7.2.8.	Economic Impact Study on Europe NGS Sample Preparation Market 
8.	Asia Pacific NGS Sample Preparation Market Overview
8.1.	Asia Pacific NGS Sample Preparation Market Size & Forecast, 2016-2027
8.1.1.	Demand
8.1.1.1.	By Value (USD Million)
8.2.	Asia Pacific NGS Sample Preparation Market Share & Forecast, 2016-2027
8.2.1.	By Product 
8.2.1.1.	Reagent & Consumables
8.2.1.2.	Workstations
8.2.2.	By Workflow 
8.2.2.1.	Library Preparation 
8.2.2.1.1.	DNA
8.2.2.1.2.	RNA
8.2.2.2.	Target Enrichment 
8.2.2.2.1.	Targeted Sequencing
8.2.2.2.2.	Whole Exome Sequencing
8.2.2.2.3.	Others
8.2.2.3.	Quality Control
8.2.3.	By Technology 
8.2.3.1.	Sequencing By Synthesis (Sbs)
8.2.3.2.	Ion Semiconductor Sequencing
8.2.3.3.	Single-Molecule Real-Time Sequencing (Smrt)
8.2.3.4.	Nanopore Sequencing
8.2.3.5.	Others
8.2.4.	By Application 
8.2.4.1.	Diagnosis
8.2.4.1.1.	Infectious Disease
8.2.4.1.2.	Cancer Diagnostics
8.2.4.1.3.	Reproductive Health Diagnostics
8.2.4.2.	 Drug Discovery,
8.2.4.3.	Agricultural & Animal Research
8.2.4.4.	Others
8.2.5.	By End-User
8.2.5.1.	Academic Institutes & Research Centers
8.2.5.2.	Hospitals & Clinics
8.2.5.3.	Pharmaceutical & Biotechnology Companies 
8.2.5.4.	Others
8.2.6.	By Country
8.2.6.1.	China
8.2.6.2.	India
8.2.6.3.	Japan
8.2.6.4.	Australia
8.2.6.5.	Rest of Asia Pacific
8.2.7.	Company Market Share (Top 3-5)
8.2.8.	Economic Impact Study on Asia Pacific NGS Sample Preparation Market 
9.	South America NGS Sample Preparation Market Overview
9.1.	South America NGS Sample Preparation Market Size & Forecast, 2016-2027
9.1.1.	Demand
9.1.1.1.	By Value (USD Million)
9.2.	South America NGS Sample Preparation Market Share & Forecast, 2016-2027
9.2.1.	By Product 
9.2.1.1.	Reagent & Consumables
9.2.1.2.	Workstations
9.2.2.	By Workflow 
9.2.2.1.	Library Preparation 
9.2.2.1.1.	DNA
9.2.2.1.2.	RNA
9.2.2.2.	Target Enrichment 
9.2.2.2.1.	Targeted Sequencing
9.2.2.2.2.	Whole Exome Sequencing
9.2.2.2.3.	Others
9.2.2.3.	Quality Control
9.2.3.	By Technology 
9.2.3.1.	Sequencing By Synthesis (Sbs)
9.2.3.2.	Ion Semiconductor Sequencing
9.2.3.3.	Single-Molecule Real-Time Sequencing (Smrt)
9.2.3.4.	Nanopore Sequencing
9.2.3.5.	Others
9.2.4.	By Application 
9.2.4.1.	Diagnosis
9.2.4.1.1.	Infectious Disease
9.2.4.1.2.	Cancer Diagnostics
9.2.4.1.3.	Reproductive Health Diagnostics
9.2.4.2.	 Drug Discovery,
9.2.4.3.	Agricultural & Animal Research
9.2.4.4.	Others
9.2.5.	By End-User
9.2.5.1.	Academic Institutes & Research Centers
9.2.5.2.	Hospitals & Clinics
9.2.5.3.	Pharmaceutical & Biotechnology Companies 
9.2.5.4.	Others
9.2.6.	By Country
9.2.6.1.	Brazil
9.2.6.2.	Argentina
9.2.6.3.	Rest of South America
9.2.7.	Company Market Share (Top 3-5)
9.2.8.	Economic Impact Study on South America NGS Sample Preparation Market
10.	Middle East & Africa NGS Sample Preparation Market Overview
10.1.	Middle East & Africa NGS Sample Preparation Market Size & Forecast, 2016-2027
10.1.1.	Demand
10.1.1.1.	By Value (USD Million)
10.2.	Middle East & Africa NGS Sample Preparation Market Share & Forecast, 2016-2027
10.2.1.	By Product 
10.2.1.1.	Reagent & Consumables
10.2.1.2.	Workstations
10.2.2.	By Workflow 
10.2.2.1.	Library Preparation 
10.2.2.1.1.	DNA
10.2.2.1.2.	RNA
10.2.2.2.	Target Enrichment 
10.2.2.2.1.	Targeted Sequencing
10.2.2.2.2.	Whole Exome Sequencing
10.2.2.2.3.	Others
10.2.2.3.	Quality Control
10.2.3.	By Technology 
10.2.3.1.	Sequencing By Synthesis (Sbs)
10.2.3.2.	Ion Semiconductor Sequencing
10.2.3.3.	Single-Molecule Real-Time Sequencing (Smrt)
10.2.3.4.	Nanopore Sequencing
10.2.3.5.	Others
10.2.4.	By Application 
10.2.4.1.	Diagnosis
10.2.4.1.1.	Infectious Disease
10.2.4.1.2.	Cancer Diagnostics
10.2.4.1.3.	Reproductive Health Diagnostics
10.2.4.2.	 Drug Discovery,
10.2.4.3.	Agricultural & Animal Research
10.2.4.4.	Others
10.2.5.	By End-User
10.2.5.1.	Academic Institutes & Research Centers
10.2.5.2.	Hospitals & Clinics
10.2.5.3.	Pharmaceutical & Biotechnology Companies 
10.2.5.4.	Others
10.2.6.	By Country
10.2.6.1.	Saudi Arabia
10.2.6.2.	UAE
10.2.6.3.	South Africa
10.2.6.4.	Rest of Middle East & Africa
10.2.7.	Company Market Share (Top 3-5)
10.2.8.	Economic Impact Study on Middle East & Africa NGS Sample Preparation Market
11.	Competitor Analysis
11.1.	Company Description
11.2.	Financial Analysis
11.3.	Key Products
11.4.	Key Management Personnel 
11.5.	Contact Address
11.6.	SWOT Analysis
11.7.	Company Profile
11.7.1.	Illumina Inc.
11.7.2.	Thermo Fisher Scientific
11.7.3.	QIAGEN N.V.
11.7.4.	 Agilent Technologies, Inc.
11.7.5.	Beckman Coulter
11.7.6.	Becton
11.7.7.	Dickinson and Company 
11.7.8.	Pacific Biosciences of California
11.7.9.	PerkinElmer Inc.
11.7.10.	F. Hoffmann-La Roche
11.7.11.	New England Biolabs, Inc.
11.7.12.	NuGEN Technologies
11.7.13.	Other Prominent Players